Q2 INTERIM REPORT APRIL - JUNE 2022
READ MORE
Mentice acquires Ankyras solutions from Galgo Medical SL
READ MORE

Mentice engages Pareto Securities as liquidity provider

Thursday, October 1, 2020

Mentice AB (publ), a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, engages Pareto Securities as liquidity provider

Mentice AB (publ) has entered into an agreement with Pareto Securities whereby Pareto Securities will act as liquidity provider for the Mentice share. The assignment takes place within the framework of Nasdaq First North Growth Market’s liquidity provision rules and means that the liquidity provider quotes a buy and sell volume corresponding to at least SEK 20,000, with a maximum spread of 4% between the bid and ask price. The purpose is to promote the share’s liquidity, and the assignment commences on Thursday October 1, 2020.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: 
goran.malmberg@mentice.com

US Mobile. +1 (312) 860 5610

Sweden Mobile +46 (0) 703 09 22 22

About Mentice

Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions. More information on www.mentice.com

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, at 08.00 on October 1, 2020.  

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399

DELÅRSRAPPORT Q2 APRIL - JUNI 2022
LÄS MER
Mentice förvärvar Ankyras från det spanska företaget Galgo Medical S.L.
LÄS MER

Mentice engages Pareto Securities as liquidity provider

Thursday, October 1, 2020

Mentice AB (publ), a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, engages Pareto Securities as liquidity provider

Mentice AB (publ) has entered into an agreement with Pareto Securities whereby Pareto Securities will act as liquidity provider for the Mentice share. The assignment takes place within the framework of Nasdaq First North Growth Market’s liquidity provision rules and means that the liquidity provider quotes a buy and sell volume corresponding to at least SEK 20,000, with a maximum spread of 4% between the bid and ask price. The purpose is to promote the share’s liquidity, and the assignment commences on Thursday October 1, 2020.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: 
goran.malmberg@mentice.com

US Mobile. +1 (312) 860 5610

Sweden Mobile +46 (0) 703 09 22 22

About Mentice

Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions. More information on www.mentice.com

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, at 08.00 on October 1, 2020.  

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399